Abstract:
Background
HBV vaccine is known to offer protection against transmission of HBV infection. Health care workers are mandated to have this vaccination as part of their occupational health safety measures. Post vaccination response data for HCWs in our setting is not available. This study therefore aimed to evaluate the anti-HBs titre levels after Hepatitis B vaccination among HCWs from selected heath facilities in the Cape Coast Metropolis, Ghana.
Methods
A multicenter (3 selected sites) analytical cross-sectional study involving 711 HCWs was conducted. Five (5mls) of blood samples were collected from each study participant and the serum used for HBV immunological profile testing anti-HBs quantification by ELISA test (Fortress Diagnostics Limited, Northern Ireland, United Kingdom). Data analyses were performed using Stata version 14.0 software (STATA Corp, Texas USA).
Results
The median age of participants was 29 years (IQR = 26–35 years). Majority (80.9%, n =
575) took their vaccination from Government health facilities compared with 19.1% (n =
136) from private vaccination sources. A total of 7 (3 males and 4 females) were found to
be HBsAg positive giving prevalence of 1%. In all, 8.2% (n = 58) of the HCWs had anti-HBs
titre levels <10IU/ml giving a sero-protection rate of 91.8%. HCWs who received 3 doses
of HBV vaccine were more likely to be sero-protected as compared to those who received
only one dose in multivariate analysis (aOR = 3.39, 95%CI: 1.08–10.67), p<0.037). Gender,
cigarette smoking and alcohol consumption were not found to be associated with seroprotection. Conclusion
There is a high HBV vaccine efficacy among HCWs in the Cape Coast Metropolis of Ghana with higher prevalence of anti-HBs titre level associated with full vaccine dose adherence. Post vaccination antibody titre determination could be an integral part of HBV vaccination protocol for HCWs in Ghana.
